Quest Diagnostics projects $11.95B-$12.05B 2026 revenue while raising EPS outlook again
Seeking Alpha ·
Earnings Call Insights: Quest Diagnostics (DGX) Q2 2026 "Our strong performance in the second quarter demonstrates focused execution of our strategy to connect people and providers to innovative testing and actionable insights... In the quarter, we grew revenues by over
DYAX Investor Sentiment
Bullish (Long) 34% · Bearish (Short) 66%
364 participants
Related News
- RLI outlines $250M share repurchase program while returning $2 special dividend in Q2 2026
- Blackstone outlines BXDC and sees stabilized data centers growing to $1T over time
- NetSTREIT targets $700M-$800M of 2026 net investment activity while lifting AFFO/share range to $1.37-$1.39
- Sonoco outlines $7.25B-$7.75B 2026 sales outlook as it targets ~10,000 tons of saturating URB by year-end
- Thermo Fisher signals 2026 revenue of $47.4B-$48.1B and adjusted EPS of $24.93-$25.33 as customer activity strengthens
- U.S. manufacturer plans to build Ukrainian naval drones under new partnership
